Statistics for Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes
Total visits
| views | |
|---|---|
| Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes | 78 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1689946.pdf | 128 |
| java.util.UUID:9911af93-f721-4c68-9ef1-b27e8a968d1b | 65 |
| java.util.UUID:91c615ba-7c87-4a0f-ac40-0a0db94199c6 | 10 |
| java.util.UUID:b3d8b8e6-25f4-45ab-9ec9-b4bf930f2d67 | 5 |
Top country views
| views | |
|---|---|
| United States | 63 |
| Bulgaria | 4 |
| Algeria | 1 |
| Israel | 1 |
| Malaysia | 1 |
| Thailand | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 44 |
| Fairfield | 6 |
| Sofia | 4 |
| Ann Arbor | 2 |
| Cambridge | 2 |
| Houston | 2 |
| Algiers | 1 |
| Andover | 1 |
| Falls Church | 1 |
| Haifa | 1 |
| San Francisco | 1 |
| Seremban | 1 |
| Washington | 1 |